U.S. Capital Markets Stock News

NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

DexCom (DXCM) Launches New Stelo App As It Expands Into Four Countries

DexCom is rolling out a redesigned Stelo app in July that aims to provide more accessible and actionable glucose insights to users. The company is preparing to launch Stelo in the UK, Australia, New Zealand, and South Korea, marking a push into new international markets. These moves follow recent FDA clearance for over the counter pediatric use of Stelo in the U.S. DexCom, trading on NasdaqGS:DXCM, is making these product and geographic moves as its stock trades around $70.14. The share...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Launches StorageGRID 12.1 And Expands CGI Alliance For AI Workloads

NetApp launched StorageGRID 12.1, a new release designed for AI scale workloads and modern data use cases. The company expanded its global alliance with CGI to offer subscription based, AI ready data infrastructure across hybrid cloud environments. These moves aim to support enterprises operating across globally distributed settings with higher performance and security for AI and data intensive applications. NetApp (NasdaqGS:NTAP) is drawing fresh attention as it pushes deeper into AI...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

How Investors Are Reacting To Capital Clean Energy Carriers (CCEC) LNG Bunkering Joint Venture Entry

Earlier in June 2026, CMA CGM S.A. and Capital Clean Energy Carriers Corp. formed a 50/50 joint venture to build, charter, and operate a 20,000 cbm dual-fuel LNG bunkering vessel, ordered from Nantong CIMC Sinopacific Offshore & Engineering for US$82.8 million with delivery targeted for the third quarter of 2028. This move marks Capital Clean Energy Carriers’ entry into the LNG bunkering market, backed by an expected 12-year time charter with a CMA CGM–TotalEnergies venture that could...
NYSE:TYL
NYSE:TYLSoftware

Tyler Technologies (TYL) Stock After 49% Slide Is The Market Overreacting

If you are wondering whether Tyler Technologies is attractively priced or still has room to fall, the recent share performance gives a clear starting point for assessing value. The stock last closed at US$294.40, with a gain of 5.6% over the past week, but it remains down 2.7% over the past month, 32.5% year to date and 49.3% over the past year. These moves have come alongside ongoing interest in how Tyler Technologies is positioned in the software sector and how investors are reassessing...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (BIIB) Is Betting Its Next Phase Of Growth On Four New Drugs

Biogen (NasdaqGS:BIIB) is shifting its focus from older multiple sclerosis and Spinraza products to newer drugs in Alzheimer's, Friedreich’s ataxia, ALS, and depression. The company is leaning on recently launched therapies such as Leqembi, Skyclarys, Qalsody, and Zurzuvae to help offset pressure on its legacy franchises. This transition comes as competition from generics and biosimilars weighs on Biogen’s established revenue base. Biogen sits at the center of several high-profile treatment...
NYSE:WS
NYSE:WSMetals and Mining

Worthington Steel (WS) Stock Q4 Net Loss Challenges Margin Recovery Narrative

Worthington Steel (WS) has just reported FY 2026 results, with Q4 revenue of $929.2 million and a basic EPS loss of $0.98. This caps a trailing twelve month period where revenue totaled $3.4 billion and EPS came in at $0.35. Over recent quarters, the company has seen revenue move from $832.9 million and EPS of $1.13 in FY 2025 Q4 to a range between $769.8 million and $929.2 million, with EPS spanning from $0.21 to a loss of $0.98 in FY 2026. This sets a mixed backdrop for its latest release...
NasdaqGM:CEPL
NasdaqGM:CEPLElectrical

Capstone Energy+ (OTCPK:CGEH) Stock Faces Lofty P/E As Recent Profitability Fuels Bullish Narratives

Capstone Energy+ (OTCPK:CGEH) has just wrapped up FY 2026 with fourth quarter revenue of US$23.0 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$106.0 million and basic EPS of US$0.14 that capture its recent move into profitability. Over the past six reported quarters, revenue has ranged between US$20.1 million and US$28.4 million per quarter, while quarterly EPS has swung from a loss of US$1.79 to a profit of US$0.06. This gives investors a clear view of how...
NasdaqCM:ZENA
NasdaqCM:ZENASoftware

Is ZenaTech (ZENA) Undervalued After Its Green Earth Deal And Zoo Office Launch?

ZenaTech (NasdaqCM:ZENA) is back on investor radars after acquiring Florida based Green Earth Powerwashing and outlining Zoo Office, an AI powered productivity platform that broadens its reach across drone services and enterprise software. See our latest analysis for ZenaTech. The recent acquisition of Green Earth Powerwashing and the Zoo Office announcement have coincided with short term momentum in ZenaTech, with a 1 day share price return of 11.43% and a 7 day share price return of 9.86%...
NYSE:RAMP
NYSE:RAMPSoftware

How LiveRamp’s Adobe GenStudio Integration At LiveRamp Holdings (RAMP) Has Changed Its Investment Story

On 23 June 2026, LiveRamp announced a new integration with Adobe GenStudio for Commerce Media Networks, bringing commerce purchase data into Adobe’s agentic content supply chain to help brands build and launch more targeted campaigns. The integration allows commerce media networks to form cohorts based on real purchase behavior and pair them with tailored, AI-generated creative, moving brands away from modeled audiences toward campaigns shaped by what customers have actually bought. Next,...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Stock After 127% One-Year Surge Is It Too Late To Buy?

If you are wondering whether ATI is still attractively priced after a strong run, the starting point is understanding what the current market price is really reflecting. The stock recently closed at US$197.40, with returns of 16.2% over the past month, 65.6% year to date and 127.4% over the last year, while the past three years show a 346.3% gain and the past five years a very large increase. Recent coverage has focused on ATI's share price performance and how investor expectations have...
NasdaqGS:AXNX
NasdaqGS:AXNXMedical Equipment

3 US Defensive Stocks Built Around Steady Healthcare Demand

With earnings sending mixed signals, energy markets reacting to geopolitical headlines, and investors watching every word from the Federal Reserve, defensiveness can look more appealing than chasing the latest growth story. This article focuses on large, established companies that tend to sit in steadier parts of the market, where cash flows often hold up better through economic swings. From this Defensive Stocks screener, three stocks appear closely tied to the current news cycle in a...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata Stock Leads 3 Professional Services Picks As AI Hiring Demand Builds

Professional and business services stocks are sitting close to the action as job openings climb to 7.6 million and companies juggle strong labor demand with slower hiring. More roles posted, fewer people hired, and fewer workers quitting create a very specific backdrop for firms that advise, support, and outsource work for employers. With the Federal Reserve expected to keep rates steady, some businesses may lean harder on external service providers instead of adding full time staff. This...
NYSE:HUM
NYSE:HUMHealthcare

Humana Stock And 2 Regulated Industry Leaders Worth Watching Now

Regulated industries are back in focus as fresh policy shifts, new rules and unsettled market sentiment push investors to rethink where they want exposure. When regulation and economic policy are in motion, large caps with solid health metrics can sometimes offer a steadier way to stay invested, or a reason to step aside. This Regulated Industries Leaders screener filters for bigger Financials and Healthcare stocks that appear well placed against the latest headlines. Below, three stocks that...
NYSE:CE
NYSE:CEChemicals

Celanese (CE) Teams Up With Siegwerk On Bio Based Solvent For Printing Inks

Celanese (NYSE:CE) has entered a collaboration with Siegwerk to supply bio-based ethyl acetate for more sustainable printing ink solutions. The partnership focuses on offering a drop-in solvent alternative that aims to reduce reliance on fossil-based materials in packaging and printing applications. For investors tracking Celanese, the Siegwerk collaboration highlights how the company is positioning its specialty chemicals portfolio around lower-impact materials. Celanese already operates...
NYSE:CMC
NYSE:CMCMetals and Mining

Commercial Metals (CMC) Stock Faces Narratives As Net Margin Rebuild Reaches 6.7%

Commercial Metals (CMC) just turned in a busy Q3 2026, with revenue of about US$2.5b and basic EPS of US$1.56, backed by trailing twelve month revenue of roughly US$8.9b and EPS of US$5.35 that frame the latest quarterly run rate. Over the past year, the company has seen revenue move from about US$7.8b on a trailing basis to roughly US$8.9b, while quarterly EPS ranged from US$0.74 in Q3 2025 to US$1.60 in Q1 2026 before landing at US$1.56 this quarter. This gives investors a clearer view of...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

3 US Value Stocks Worth A Closer Look As Inflation Holds At 4.1%

Inflation at 4.1%, shifting expectations for Fed rate moves and volatile energy prices linked to events in Iran are reshaping how investors look at US value stocks. When markets rethink what cash flows are worth under changing interest rate assumptions, some companies can stand out on traditional measures like P/E, P/B and price to cash flow. This article uses a US Value Stocks screener, built around those valuation metrics and balance sheet strength, to spotlight 3 stocks that appear...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX (SNX) Stock EPS Surge Tests Cautious Growth Narratives After Q2 2026 Results

TD SYNNEX (SNX) has just posted Q2 2026 results with revenue of US$19.6 billion and basic EPS of US$4.20, alongside trailing twelve month revenue of US$69.8 billion and EPS of US$14.03 that reflect the impact of the last four quarters. Over the past year, the company has seen revenue move from US$14.9 billion in Q2 2025 to US$19.6 billion in Q2 2026, while quarterly EPS went from US$2.22 to US$4.20, with trailing twelve month EPS stepping up from US$8.61 to US$14.03 over the same period. For...
NYSE:ASAN
NYSE:ASANSoftware

Asana (ASAN) Wins FedRAMP Approval For Asana Gov And Opens New Government Doors

Asana (NYSE:ASAN) reported that its Asana Gov platform has achieved FedRAMP Moderate Authorization. This certification allows Asana Gov to be used by U.S. federal, state, and local government agencies, contractors, and educational institutions with defined security and compliance needs. The authorization marks an expansion of Asana's addressable market within regulated public sector environments. Asana is best known for its work management and collaboration software, used by teams to...
NYSE:TOST
NYSE:TOSTDiversified Financial

Higher Rates Keep Banks And Insurers In Focus With 3 Stocks To Watch

Sticky inflation, a higher for longer interest rate outlook from the Fed, and energy costs linked to Middle East tensions are reshaping how investors think about banks and insurance stocks. With headline inflation at 4.1% and core inflation at 3.4%, and no clear sign of quick rate relief, the cost of money and risk pricing are front and center again. This article looks at three large, financially healthy Financials stocks from our screener that appear well aligned with this backdrop, and...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Seeks 20 Year Renewals For Two New York Nuclear Plants

Constellation Energy (NasdaqGS:CEG) has applied for 20-year license renewals for its Ginna and Nine Mile Point Unit 1 nuclear plants in New York. The proposed extensions would allow the reactors to operate until 2049, subject to regulatory approval. The plants are backed by New York's Zero Emissions Credit program, which supports carbon free generation. Constellation Energy is a major US producer of carbon free electricity, and its New York reactors are part of a broader focus on nuclear...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

NBT Bancorp (NBTB) Stock After Strong Multi‑Year Run Are Recent Gains Already Priced In

If you are wondering whether NBT Bancorp is still reasonably priced after its recent run, the current valuation picture offers a few clear clues and some gray areas worth unpacking. The stock last closed at US$49.26, with returns of 5.5% over 7 days, 5.8% over 30 days, 18.4% year to date, 22.2% over 1 year, 67.7% over 3 years, and 60.2% over 5 years, which naturally raises questions about what is already reflected in the price. Recent news around NBT Bancorp has focused on its position...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth (AHCO) Gains On Reaffirmed Buy Rating, Is It Still A Bargain?

AdaptHealth (AHCO) shares moved after a Truist Securities analyst reiterated a positive rating following recent meetings with management, a reminder that investor sentiment often reacts quickly to updated views on a company’s outlook. See our latest analysis for AdaptHealth. At a share price of US$10.02, AdaptHealth has seen a 7 day share price return of 3.83%, but its 90 day share price return is down 10.54% and the 5 year total shareholder return is down 63.24%. This indicates that recent...
NYSE:CARR
NYSE:CARRBuilding

Daikin Stock And Europe’s Heatwave Spending Opportunity

Extreme heat is moving from a long term climate concern to a very present investment issue for European markets, as record temperatures strain power grids, public services, and buildings that were never designed for this kind of weather. For investors, this raises practical questions about which stocks could see stronger demand from heat adaptation spending and where the risks might be rising. This article looks at three stocks exposed to the current European heatwave theme through their...
NasdaqGS:COUP
NasdaqGS:COUPSoftware

3 Software Stocks Helping Companies Rein In AI Costs

Enterprise AI is hitting a cost reality check as companies rein in token usage, push for cheaper models, and question how much they are willing to spend on premium providers like OpenAI and Anthropic. That puts cost-optimization software in the spotlight, as boards and finance teams look for clearer views on IT and AI spend, stronger controls, and better value from existing contracts. This article looks at 3 stocks from an Enterprise Cost-Optimization Software Providers screener that appear...